Published in Cancer Weekly, June 27th, 2000
Dr. Delbert E. Day, Curators' Professor Emeritus of ceramic engineering at the University of Missouri at Rolla, is the co-inventor of this method. The first patients to be treated with radioactive glass beads, now marketed under the name TheraSphere by MDS Nordion, will take place later this year at the Mayo Clinic in Rochester, Minnesota, and at the University of Pittsburgh School of Medicine, Pennsylvania.
The treatment consists of injecting millions of tiny, radioactive glass beads into the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.